859 related articles for article (PubMed ID: 37575318)
21. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H
Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
[TBL] [Abstract][Full Text] [Related]
22. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.
Sansoè G; Aragno M
J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705
[TBL] [Abstract][Full Text] [Related]
23. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z
J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758
[TBL] [Abstract][Full Text] [Related]
24. Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue.
Franco R; Lillo A; Rivas-Santisteban R; Rodríguez-Pérez AI; Reyes-Resina I; Labandeira-García JL; Navarro G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339432
[TBL] [Abstract][Full Text] [Related]
25. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
26. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
Obukhov AG; Stevens BR; Prasad R; Li Calzi S; Boulton ME; Raizada MK; Oudit GY; Grant MB
Diabetes; 2020 Sep; 69(9):1875-1886. PubMed ID: 32669391
[TBL] [Abstract][Full Text] [Related]
28. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
Matsuzawa Y; Kimura K; Ogawa H; Tamura K
Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
[TBL] [Abstract][Full Text] [Related]
29. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.
Quarleri J; Delpino MV
Geroscience; 2022 Apr; 44(2):547-565. PubMed ID: 35157210
[TBL] [Abstract][Full Text] [Related]
31. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients.
Kulkarni PG; Sakharkar A; Banerjee T
Hypertens Res; 2022 Feb; 45(2):254-269. PubMed ID: 34848886
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
34. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
35. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
36. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
37. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
Cao X; Song LN; Yang JK
Clin Sci (Lond); 2021 Feb; 135(3):535-554. PubMed ID: 33533405
[TBL] [Abstract][Full Text] [Related]
38. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
[TBL] [Abstract][Full Text] [Related]
39. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
Brojakowska A; Narula J; Shimony R; Bander J
J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
[TBL] [Abstract][Full Text] [Related]
40. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]